CA2371695A1 - Augmentation de fertilite induite par des morphogenes - Google Patents

Augmentation de fertilite induite par des morphogenes Download PDF

Info

Publication number
CA2371695A1
CA2371695A1 CA002371695A CA2371695A CA2371695A1 CA 2371695 A1 CA2371695 A1 CA 2371695A1 CA 002371695 A CA002371695 A CA 002371695A CA 2371695 A CA2371695 A CA 2371695A CA 2371695 A1 CA2371695 A1 CA 2371695A1
Authority
CA
Canada
Prior art keywords
bmp
morphogen
xaa xaa
seq
gdf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002371695A
Other languages
English (en)
Inventor
Kuber T. Sampath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Curis Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2371695A1 publication Critical patent/CA2371695A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Abstract

L'invention concerne des procédés et compositions pour le traitement de l'infertilité humaine, par administration de morphogènes destinés à réguler la croissance des follicules ovariens. L'invention concerne également des procédés et compositions servant à retarder l'apparition de la ménopause ou à en atténuer les symptômes, ainsi que des procédés et compositions servant à diminuer la fertilité.
CA002371695A 1999-04-30 2000-04-28 Augmentation de fertilite induite par des morphogenes Abandoned CA2371695A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13172199P 1999-04-30 1999-04-30
US60/131,721 1999-04-30
US56117100A 2000-04-27 2000-04-27
US09/561,171 2000-04-27
PCT/US2000/011501 WO2000066620A2 (fr) 1999-04-30 2000-04-28 Augmentation de fertilite induite par des morphogenes

Publications (1)

Publication Number Publication Date
CA2371695A1 true CA2371695A1 (fr) 2000-11-09

Family

ID=26829736

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002371695A Abandoned CA2371695A1 (fr) 1999-04-30 2000-04-28 Augmentation de fertilite induite par des morphogenes

Country Status (4)

Country Link
EP (1) EP1181041A2 (fr)
AU (1) AU4676600A (fr)
CA (1) CA2371695A1 (fr)
WO (1) WO2000066620A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ519330A (en) * 2002-05-30 2004-12-24 George Henry Davis New sequences for altering mammalian ovarian function and ovulation rate
PL2981822T3 (pl) 2013-05-06 2021-07-12 Scholar Rock, Inc. Kompozycje i sposoby modulacji czynnika wzrostu

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0601135B1 (fr) * 1991-08-30 2005-11-02 Curis, Inc. Proteines osteogeniques pour le traitement des maladies osseuses metaboliques
US6030617A (en) * 1993-01-12 2000-02-29 The Johns Hopkins University School Of Medicine Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation
ES2213745T3 (es) * 1993-05-12 2004-09-01 Genetics Institute, Llc Composiciones de bmp-11.
EP1559726A3 (fr) * 1993-10-08 2006-01-25 The Johns Hopkins University School Of Medicine Facteur 10 de la differentiation de croissance
CA2247502A1 (fr) * 1996-02-28 1997-09-04 Vanderbilt University Compositions et procedes de production de cellules souches embryonnaires
US5965403A (en) * 1996-09-18 1999-10-12 Genetics Institute, Inc. Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
EP2309261A1 (fr) * 1997-05-30 2011-04-13 Stryker Corporation Procédés d'évaluation de la morphogénèse de tissus et activité

Also Published As

Publication number Publication date
AU4676600A (en) 2000-11-17
WO2000066620A3 (fr) 2001-01-18
EP1181041A2 (fr) 2002-02-27
WO2000066620A2 (fr) 2000-11-09

Similar Documents

Publication Publication Date Title
US6407060B1 (en) Method for enhancing functional recovery following central nervous system ischemia or trauma
US20060239951A1 (en) Methods for stimulating hair growth by administering BMPs
US8536128B2 (en) Granulin/epithelin precursor (GEP), a chondrogenic growth factor and target in cartilage disorders
US7147839B2 (en) Methods for evaluating tissue morphogenesis and activity
US20040176292A1 (en) Methods and compositions for enhancing cognitive function using morphogenic proteins
US6696410B1 (en) Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors
JP2001501096A (ja) 新規のモルフォゲン応答性シグナルトランスデューサーおよびその使用方法
CA2349038C (fr) Procedes servant a soulager les symptomes du cancer
AU742663B2 (en) Methods for evaluating tissue morphogenesis and activity
CA2307826A1 (fr) Amelioration d'activite morphogene
CA2371695A1 (fr) Augmentation de fertilite induite par des morphogenes
AU741350B2 (en) Treatment of mammalian myocardium with morphogen locally, or with morphogenically-treated myogenic precursor cells
US20140107026A1 (en) Bone morphogenetic proteins for the treatment of insulin resistance
AU763488B2 (en) Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells
EP0956038A1 (fr) Regeneration induite par peptide morphogene de tissus percepto-sensoriels
US20110046047A1 (en) Bone Morphogenetic Proteins for Appetite Control
CA2323078A1 (fr) Compositions pour moduler la differentiation des cellules comprenant un lipide et un morphogene
CA2385887A1 (fr) Compositions et methodes therapeutiques utilisant des proteines morphogeniques, des hormones et des recepteurs d'hormones

Legal Events

Date Code Title Description
FZDE Dead